• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Novavax COVID Vaccine 140 Million Dose Order Canceled by Japan, Takeda Reveals

Article

In 2021, Takeda announced a partnership with Novavax to manufacture 150 million doses of the Nuvaxovid COVID-19 vaccine; however, the Japanese government has canceled its order for the remaining 141.76 million doses due to low demand.

Japan's cancellation of the Novavax vaccine order will not significantly impact Takeda's finances and the company is not altering its full-year consolidated forecasts.

Recent Videos
Related Content
Credit: cacaroot | stock.adobe.com

Pharma Marketing's Top Movers and Shakers in 2024

December 20th 2024
Article

These professionals in the healthcare marketing sector have been chosen by their peers for making big moves and taking on larger roles.

Gen-Z Influence on Pharma M&A

Gen-Z Influence on Pharma M&A

Miranda Schmalfuhs
March 14th 2024
Podcast

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Tanveer Ahmed Nasir;Pooja Jain
December 13th 2024
Article

A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.

Transforming Cancer Care: Data, AI, and Patient-Centered Care

Transforming Cancer Care: Data, AI, and Patient-Centered Care

Francis Pollaro
July 20th 2023
Podcast

Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.

AI: A Value Advantage? Maximizing Your Brand Outreach

AI: A Value Advantage? Maximizing Your Brand Outreach

Avinob Roy
October 14th 2024
Article

Practical ways product teams can leverage the benefits of generative artificial intelligence as a strategic advantage in pharmaceutical and life sciences commercialization.

Stock.adobe.com

eHealth Survey Reveals Concerns Prior to Medicare Enrollment

Mike Hollan
October 14th 2024
Article

Respondents showed concern for cost increases and changes to benefits.